Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Valneva SE made materially false and/or misleading statements and/or failed to disclose that: On February 25, 2025, the U.S. Centers for Disease Control and Prevention ("CDC") posted a notice on its website announcing that "CDC is currently investigating five hospitalizations for cardiac or neurologic events following vaccination with IXCHIQ [Valneva's chikungunya virus vaccine] among people 65 years of age and older." Following this announcement and subsequent reporting by media outlets, Valneva's American Depositary Receipt ("ADR") price fell over 13% on February 28, 2025.
In order to be eligible to join the VALN class action lawsuit, you must have incurred a loss on shares of Valneva SE purchased during the class period listed above.
TOP
